as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹516.85
Change
-1.6 (-0.31%)
Open
₹518.45
Prev. Close
₹518.45
Day High
₹526.95
Day Low
₹511.8
Volume Analysis
Traded
232,297
Delivered
101,063
Delivery %
43.51%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (2)
- •Strong return on equity (52.1%)
- •Strong operating margin (41.0%)
Weaknesses (1)
- •Promoter holding is falling
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹540.41 | ₹533.68 | ₹525.26 | ₹518.53 | ₹510.11 | ₹503.38 | ₹494.96 |
| Fibonacci | ₹533.68 | ₹527.89 | ₹524.32 | ₹518.53 | ₹512.74 | ₹509.17 | ₹503.38 |
| Camarilla | ₹521.02 | ₹519.63 | ₹518.24 | ₹518.53 | ₹515.46 | ₹514.07 | ₹512.68 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-2.3%
1 Week
-4.16%
1 Month
+4.33%
3 Months
-13.3%
6 Months
+17.19%
1 Year
-10.58%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
DuPont ROE Breakdown
40.04%
Net margin 27.25% × asset turnover 0.93x × equity multiplier 1.58x
Company Overview
Sector
Healthcare
Market Cap
₹9,989 Cr
P/E (TTM)
70.9
ROE
52.1%
Face Value
₹2.0
Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.
TopFund Analysis
Blue Jet Healthcare Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 61/100. The strongest factor is Financial Strength (100/100), while Valuation (2/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (52.1%); strong operating margin (41.0%); promoter holding is falling. FII holding has been falling.
TopFund Score — Fundamentals Quality
61/100 — AverageData confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has reduced debt.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Signed non-binding MoU with Andhra Pradesh for phased ₹500 crore API manufacturing facility on 50 acres.
Transcript of Earnings call with analysts/Investors on Financial Result for the Quarter and Half Yearly ended 30th September, 2026.
Newspaper Publication of Financial Results pertaining to Quarter and half year ended September 30, 2026
Audio recording of Q2 and H1 FY2026 earnings conference call posted on website.
CARE monitoring report for Blue Jet’s ₹800 crore QIP; ₹245.91 crore utilized, no deviation.
Source: BSE regulatory filings, via Screener.in.
Profit & Loss (Yearly)
| Mar 2020 | Mar 2021 | |
|---|---|---|
| Sales + | 538 | 499 |
| Expenses + | 324 | 293 |
| Operating Profit | 214 | 206 |
| OPM % | 40.0% | 41.0% |
| Other Income + | 6 | 4 |
| Interest | 7 | 5 |
| Depreciation | 18 | 20 |
| Profit before tax | 194 | 185 |
| Tax % | 25.0% | 26.0% |
| Net Profit + | 145 | 136 |
| EPS in Rs | 138 | 8 |
| Dividend Payout % | 0.0% | 0.0% |
| Sales growth | — | -7 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2020 | Mar 2021 | |
|---|---|---|
| Reserves | 201 | 330 |
| Borrowings + | 79 | 53 |
| Other Liabilities + | 95 | 143 |
| Total Liabilities | 375 | 536 |
| Fixed Assets + | 107 | 139 |
| CWIP | 2 | 3 |
| Investments | 34 | 37 |
| Other Assets + | 232 | 358 |
| Total Assets | 375 | 536 |
| Equity Capital | 1 | 10 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2020 | Mar 2021 | |
|---|---|---|
| Cash from Operating Activity + | 123 | 129 |
| Cash from Investing Activity + | -45 | -51 |
| Cash from Financing Activity + | -72 | -28 |
| Net Cash Flow | 5 | 51 |
| Free Cash Flow | 107 | 80 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 80 | 63 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 7.37% | 8.97% | 9.83% | 10.06% | 10.87% | 10.38% | 11.08% | 14.74% | 14.41% | 14.8% | 15.14% | 18.56% |
| Promoters | 86.0% | 86.0% | 86.0% | 86.0% | 86.0% | 86.0% | 86.0% | 79.81% | 79.81% | 79.81% | 79.81% | 73.15% |
| FII | 2.93% | 2.01% | 2.02% | 2.18% | 1.1% | 2.28% | 1.97% | 1.83% | 1.14% | 0.89% | 0.4% | 0.81% |
| DII | 3.7% | 3.04% | 2.14% | 1.75% | 2.02% | 1.33% | 0.95% | 3.63% | 4.65% | 4.51% | 4.65% | 7.48% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Blue Jet Healthcare Ltd (this stock) | 9,989 | 70.9 | — | 52.1% |
| Yatharth Hosp & Tra C S L | 10,222 | 53.6 | 5.44 | 10.2% |
| Symbiotec Pharmalab Ltd | 10,354 | 70.0 | 7.6 | 11.7% |
| Jupiter Life Line Hosp L | 9,507 | 50.0 | 5.84 | 13.1% |
| Strides Pharma Sci Ltd | 9,353 | 16.2 | 2.74 | 20.0% |
| Paras Healthcare Limited | 9,284 | 129.0 | — | 13.0% |
| Aarti Pharmalabs Limited | 9,212 | 35.4 | 4.08 | 8.59% |
Which Mutual Funds Hold Blue Jet Healthcare Ltd?
Frequently Asked Questions about Blue Jet Healthcare Ltd
Blue Jet Healthcare Ltd (BLUEJET) closed at ₹516.85 on NSE on 19 November 2026, down 1.6 (0.31%) from the previous close.
Blue Jet Healthcare Ltd trades on the NSE (National Stock Exchange of India) under the symbol BLUEJET.
Blue Jet Healthcare Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 70.9.
Blue Jet Healthcare Ltd has a dividend yield of 0.22%.
Blue Jet Healthcare Ltd's 52-week high is ₹648.0 and its 52-week low is ₹325.0.
Blue Jet Healthcare Ltd has a market capitalisation of ₹9,989 crore.
Blue Jet Healthcare Ltd has a TopFund Quality Score of 61/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Blue Jet Healthcare Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.